Overview
Cystic fibrosis is a chronic, progressive disease that affects approximately 70,000 people worldwide. It is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. In people with CF, the defective protein leads to the production of thick, sticky mucus that clogs the airways and digestive tract, causing a range of symptoms and complications.
CF affects people of all ethnic backgrounds, but it is most common in people of European ancestry. The disease is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. Carriers of the mutated gene, who have one normal and one mutated copy, are generally asymptomatic but can pass the mutated gene to their offspring.
History/Background
The first reported cases of CF date back to the 1930s, but it wasn't until the 1950s that the disease was identified as a distinct medical condition. In the 1960s and 1970s, researchers discovered the genetic basis of CF and began to develop treatments to manage the disease. The development of pulmonary function tests and chest X-rays in the 1970s and 1980s enabled healthcare providers to diagnose CF more accurately and monitor the progression of the disease.
Key Information
Key facts about cystic fibrosis include:
* Symptoms: Recurring lung infections, coughing, wheezing, shortness of breath, and digestive problems such as diarrhea, abdominal pain, and malnutrition.
* Complications: Respiratory failure, lung transplantation, and malnutrition-related complications such as osteoporosis and growth retardation.
* Treatment: Pulmonary rehabilitation, physical therapy, medications to thin mucus and manage symptoms, and liver transplantation in some cases.
* Genetic testing: Available for carriers and at-risk individuals to identify the mutated gene and predict the likelihood of developing the condition.
* Newborn screening: Mandatory in many countries to detect CF in newborns and initiate early treatment.
Significance
Cystic fibrosis is a significant public health concern due to its high mortality rate and the need for ongoing medical care and treatment. According to the Cystic Fibrosis Foundation, the average life expectancy for people with CF is around 50 years, although this has increased significantly in recent decades due to advances in treatment and care. The development of gene therapy and stem cell transplantation holds promise for future treatments and potentially a cure for CF.
